07:00 , Aug 13, 2012 |  BC Week In Review  |  Clinical News

Caldolor ibuprofen regulatory update

Cumberland disclosed in its 2Q12 earnings that Health Canada approved Caldolor ibuprofen to treat pain and fever. The company said that marketing partner Alveda Pharmaceuticals Inc. (Toronto, Ontario) began "launch activities" in Canada for the...
07:00 , Aug 15, 2011 |  BC Week In Review  |  Clinical News

Caldolor ibuprofen regulatory update

Cumberland disclosed in its 2Q11 earnings that marketing partner Alveda Pharmaceuticals Inc. (Toronto, Ontario) submitted a NDS to Health Canada for Caldolor ibuprofen to treat pain and fever. Alveda has exclusive rights from Cumberland to...
07:00 , May 10, 2010 |  BC Week In Review  |  Company News

Cumberland, Alveda Pharmaceuticals Inc. sales and marketing update

Cumberland granted Alveda an exclusive license to commercialize Caldolor ibuprofen in Canada. Alveda will be responsible for obtaining regulatory approval in Canada. Cumberland will receive an undisclosed upfront payment and will be eligible for milestones...